Boston Trust Walden Corp Raises Stake in Core Laboratories Inc. (NYSE:CLB)

Boston Trust Walden Corp increased its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 617,336 shares of the oil and gas company’s stock after purchasing an additional 16,503 shares during the period. Boston Trust Walden Corp owned 1.31% of Core Laboratories worth $10,686,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Nisa Investment Advisors LLC increased its holdings in Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock worth $42,000 after buying an additional 2,339 shares during the period. Ridgewood Investments LLC boosted its holdings in shares of Core Laboratories by 4.6% during the 4th quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company’s stock worth $565,000 after purchasing an additional 1,428 shares during the last quarter. Confluence Investment Management LLC grew its holdings in shares of Core Laboratories by 0.4% in the fourth quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company’s stock valued at $2,360,000 after purchasing an additional 599 shares during the period. JPMorgan Chase & Co. raised its position in Core Laboratories by 5.8% in the third quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company’s stock valued at $765,000 after purchasing an additional 2,267 shares during the period. Finally, Tidal Investments LLC boosted its position in shares of Core Laboratories by 1.7% during the 3rd quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock worth $813,000 after purchasing an additional 716 shares during the period. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Price Performance

Shares of Core Laboratories stock opened at $16.58 on Tuesday. The business’s fifty day moving average price is $18.76 and its 200 day moving average price is $19.32. The stock has a market capitalization of $778.29 million, a P/E ratio of 25.12, a PEG ratio of 0.99 and a beta of 2.38. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $25.13. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. As a group, research analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Monday, February 10th will be given a $0.01 dividend. The ex-dividend date of this dividend is Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.24%. Core Laboratories’s payout ratio is 6.06%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup decreased their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.